These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33805493)

  • 1. Indole Derivatives Obtained from Egyptian
    Amer MA; Wasfi R; Attia AS; Ramadan MA
    Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33805493
    [No Abstract]   [Full Text] [Related]  

  • 2. Silicone Foley catheters impregnated with microbial indole derivatives inhibit crystalline biofilm formation by
    Amer MA; Ramadan MA; Attia AS; Wasfi R
    Front Cell Infect Microbiol; 2022; 12():1010625. PubMed ID: 36118027
    [No Abstract]   [Full Text] [Related]  

  • 3. Explication of the Potential of 2-Hydroxy-4-Methoxybenzaldehyde in Hampering Uropathogenic
    Durgadevi R; Abirami G; Alexpandi R; Nandhini K; Kumar P; Prakash S; Veera Ravi A
    Front Microbiol; 2019; 10():2804. PubMed ID: 31921010
    [No Abstract]   [Full Text] [Related]  

  • 4. Virulence targeted inhibitory effect of linalool against the exclusive uropathogen
    Durgadevi R; Veera Ravi A; Alexpandi R; Krishnan Swetha T; Abirami G; Vishnu S; Karutha Pandian S
    Biofouling; 2019 May; 35(5):508-525. PubMed ID: 31144520
    [No Abstract]   [Full Text] [Related]  

  • 5. Cranberry derivatives enhance biofilm formation and transiently impair swarming motility of the uropathogen Proteus mirabilis HI4320.
    O'May C; Amzallag O; Bechir K; Tufenkji N
    Can J Microbiol; 2016 Jun; 62(6):464-74. PubMed ID: 27090825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary metabolites produced by marine streptomyces as antibiofilm and quorum-sensing inhibitor of uropathogen Proteus mirabilis.
    Younis KM; Usup G; Ahmad A
    Environ Sci Pollut Res Int; 2016 Mar; 23(5):4756-67. PubMed ID: 26538254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators, metabolic status or active pump proteins.
    Aygül A; Öztürk İ; Çilli FF; Ermertcan Ş
    Phytomedicine; 2019 Apr; 57():65-71. PubMed ID: 30668324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study.
    Elhosseini MA; El-Banna TE; Sonbol FI; El-Bouseary MM
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):48. PubMed ID: 38802894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Into the understanding the multicellular lifestyle of
    Gmiter D; Kaca W
    Front Cell Infect Microbiol; 2022; 12():864305. PubMed ID: 36118021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A correlation study between virulence factors and multidrug resistance among clinical isolates of Proteus mirabilis.
    Elhoshi M; El-Sherbiny E; Elsheredy A; Aboulela AG
    Braz J Microbiol; 2023 Sep; 54(3):1387-1397. PubMed ID: 37535261
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Manoharan A; Farrell J; Aldilla VR; Whiteley G; Kriel E; Glasbey T; Kumar N; Moore KH; Manos J; Das T
    Front Cell Infect Microbiol; 2023; 13():1216798. PubMed ID: 37965267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alhagi maurorum extract modulates quorum sensing genes and biofilm formation in Proteus mirabilis.
    Mirzaei A; Nasr Esfahani B; Ghanadian M; Moghim S
    Sci Rep; 2022 Aug; 12(1):13992. PubMed ID: 35978046
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wasfi R; Hamed SM; Amer MA; Fahmy LI
    Front Cell Infect Microbiol; 2020; 10():414. PubMed ID: 32923408
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of
    Chakkour M; Hammoud Z; Farhat S; El Roz A; Ezzeddine Z; Ghssein G
    Front Microbiol; 2024; 15():1383618. PubMed ID: 38646633
    [No Abstract]   [Full Text] [Related]  

  • 15. Virulence genes and antimicrobial resistance pattern in Proteus mirabilis strains isolated from patients attended with urinary infections to Tertiary Hospitals, in Iran.
    Tabatabaei A; Ahmadi K; Shabestari AN; Khosravi N; Badamchi A
    Afr Health Sci; 2021 Dec; 21(4):1677-1684. PubMed ID: 35283944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant
    Li Y; Yin M; Fang C; Fu Y; Dai X; Zeng W; Zhang L
    Front Cell Infect Microbiol; 2023; 13():1229194. PubMed ID: 37637463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-
    Smanthong N; Tavichakorntrakool R; Tippayawat P; Lulitanond A; Pinlaor P; Daduang J; Sae-Ung N; Chaveerach A; Phetcharaburanin J; Boonsiri P
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164357
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the growth inhibition and anti-biofilm activity of aptamer (PmA2G02) against Proteus mirabilis 1429
    Elumalai R; Vishwakarma A; Balakrishnan A; Ramya M
    Res Microbiol; 2024; 175(3):104105. PubMed ID: 37429429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
    Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.